Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Massimiliano Fabbiani; M Zaccarelli; Pierfrancesco Grima; M Prosperi; Iuri Fanti; Manuela Colafigli; Alessandro D'Avino; Annalisa Mondi; Alberto Borghetti; Massimo Fantoni; Roberto Cauda; Simona Di Giambenedetto

doi:10.1186/1471-2334-14-26

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Massimiliano Fabbiani
, M Zaccarelli^*
, Pierfrancesco Grima
, M Prosperi
, Iuri Fanti
, Manuela Colafigli
, Alessandro D'Avino
, Annalisa Mondi
, Alberto Borghetti
, Massimo Fantoni
, Roberto Cauda
, Simona Di Giambenedetto

^*Autore corrispondente per questo lavoro

S. Caterina Novella Hospital

Risultato della ricerca: Contributo in rivista › Articolo

13 Citazioni (Scopus)

Abstract

Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

Lingua originale	Inglese
pagine (da-a)	26-26
Numero di pagine	1
Rivista	BMC Public Health
Volume	14
Numero di pubblicazione	1
DOI	https://doi.org/10.1186/1471-2334-14-26
Stato di pubblicazione	Pubblicato - 2014

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Malattie Infettive

Keywords

Efavirenz
antiretroviral
nervous system
therapy

Accesso al documento

10.1186/1471-2334-14-26

Altri file e collegamenti

Cita questo

Fabbiani, M., Zaccarelli, M., Grima, P., Prosperi, M., Fanti, I., Colafigli, M., D'Avino, A., Mondi, A., Borghetti, A., Fantoni, M., Cauda, R., & Di Giambenedetto, S. (2014). Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients. BMC Public Health, 14(1), 26-26. https://doi.org/10.1186/1471-2334-14-26

@article{264b75d47f844c1aaf8f3aed7175d5da,

title = "Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy na{\"i}ve or switching for simplification HIV-infected patients",

abstract = "Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.",

keywords = "Efavirenz, antiretroviral, nervous system, therapy, Efavirenz, antiretroviral, nervous system, therapy",

author = "Massimiliano Fabbiani and M Zaccarelli and Pierfrancesco Grima and M Prosperi and Iuri Fanti and Manuela Colafigli and Alessandro D'Avino and Annalisa Mondi and Alberto Borghetti and Massimo Fantoni and Roberto Cauda and \{Di Giambenedetto\}, Simona",

year = "2014",

doi = "10.1186/1471-2334-14-26",

language = "English",

volume = "14",

pages = "26--26",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central",

number = "1",

}

Fabbiani, M, Zaccarelli, M, Grima, P, Prosperi, M, Fanti, I, Colafigli, M, D'Avino, A, Mondi, A, Borghetti, A, Fantoni, M, Cauda, R & Di Giambenedetto, S 2014, 'Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients', BMC Public Health, vol. 14, n. 1, pagg. 26-26. https://doi.org/10.1186/1471-2334-14-26

TY - JOUR

T1 - Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

AU - Fabbiani, Massimiliano

AU - Zaccarelli, M

AU - Grima, Pierfrancesco

AU - Prosperi, M

AU - Fanti, Iuri

AU - Colafigli, Manuela

AU - D'Avino, Alessandro

AU - Mondi, Annalisa

AU - Borghetti, Alberto

AU - Fantoni, Massimo

AU - Cauda, Roberto

AU - Di Giambenedetto, Simona

PY - 2014

Y1 - 2014

N2 - Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

AB - Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

KW - Efavirenz

KW - antiretroviral

KW - nervous system

KW - therapy

KW - Efavirenz

KW - antiretroviral

KW - nervous system

KW - therapy

UR - https://publicatt.unicatt.it/handle/10807/50891

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84892385636&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84892385636&origin=inward

U2 - 10.1186/1471-2334-14-26

DO - 10.1186/1471-2334-14-26

M3 - Article

SN - 1471-2458

VL - 14

SP - 26

EP - 26

JO - BMC Public Health

JF - BMC Public Health

IS - 1

ER -

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Abstract

OSS delle Nazioni Unite

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo